
Egypt has the right to produce the new hepatitis C medication (Sovaldi) without the need for having permission from the original producing company, the pharmacist syndicate said Wednesday.
The syndicate said this right emerged as Egypt was one of the countries that had a high spread of the epidemic, citing India after it signed an agreement to produce the medicine and export it to 91 other countries, secretary of the syndicate Wael Helal said.
Helal demanded conducting researches and studies on the new medicine before offering in market, noting studies that were made in the US included the two types of hepatitis C one and three, and few studies were conducted on the type four which is spread in Egypt.
Sovaldi costs USD 84,000 for a 12-week course of treatment and clinical studies indicated it has a 90% cure rate.
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor